Information  X 
Enter a valid email address

InnovaDerma PLC (IDP)

  Print      Mail a friend

Monday 12 April, 2021

InnovaDerma PLC

Publication of Prospectus

RNS Number : 2104V
InnovaDerma PLC
12 April 2021
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA (SUBJECT TO CERTAIN LIMITED EXCEPTIONS), AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED AT 09:19 A.M. 20 JANUARY 2021.

 

12 April 2021

InnovaDerma PLC

("InnovaDerma" or the "Company")

 

Publication of Prospectus

 

 

Further to the announcement today relating to the proposed Fundraising, the Company is pleased to announced the prospectus and circular (the "Prospectus") has been approved by the Financial Conduct Authority and will be published today. 

 

The Prospectus will shortly be posted to Shareholders.

 

The Prospectus also includes a notice of a general meeting of the Company, to be held in connection with the Fundraising at 10:00 a.m. on 29 April 2021. Shareholders are reminded to review carefully the actions to be taken by them in connection with the General Meeting, which are detailed in the Prospectus.

 

A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Prospectus is also available for inspection at the Company's registered office at 27 Old Gloucester Street
London WC1N 3AX and is available on the Company's website:  https://www.innovaderma.com/investor-relations/.

 

 

Further enquiries

 

InnovaDerma

Blake Hughes

 

 

c/o TB Cardew

 

finnCap Group

Geoff Nash/Kate Bannatyne/Edward Whiley

Alice Lane/Charlotte Sutcliffe - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/

Olivia Rosser

 

+ 44 (0)7775 848537

+ 44 (0)20 7930 0777

[email protected]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIITMRTMTBBBJB

a d v e r t i s e m e n t